Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Oct 9;2(4):e000272.
doi: 10.1136/esmoopen-2017-000272. eCollection 2017.

Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape

Sjoukje F Oosting  1 , Rudolf S Fehrmann  1 , Elisabeth G E de Vries  1
Affiliations
Editorial

Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape

Sjoukje F Oosting et al. ESMO Open. .
No abstract available

Keywords: independent investigator.

PubMed Disclaimer

Conflict of interest statement

Competing interests: EGEdV has received research support from Amgen, Roche/Genentech, Chugai Pharma, Synthon, Astra Zeneca, Radius Health, CytomX and Nordic Nanovector made available to the institution.

Comment on

References

    1. Negrouk A, Lacombe D, Cardoso F, et al. . Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients. ESMO Open 2017;2:e000187 10.1136/esmoopen-2017-000187 - DOI - PMC - PubMed
    1. Cherny NI, Sullivan R, Dafni U, et al. . A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS). Ann Oncol 2015;26:1547–73. 10.1093/annonc/mdv249 - DOI - PubMed
    1. Schnipper LE, Davidson NE, Wollins DS, et al. . Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received. J Clin Oncol 2016;34:2925–34. 10.1200/JCO.2016.68.2518 - DOI - PubMed
    1. Del Paggio JC, Azariah B, Sullivan R, et al. . Do contemporary randomized controlled trials meet ESMO thresholds for meaningful clinical benefit? Ann Oncol 2017;28:157–62. 10.1093/annonc/mdw538 - DOI - PubMed
    1. Unger JM, LeBlanc M, Blanke CD. The effect of positive SWOG treatment trials on survival of patients with cancer in the US population. JAMA Oncol 2017. 10.1001/jamaoncol.2017.0762 - DOI - PMC - PubMed

LinkOut - more resources